What you are describing is the testing ground of a truly personalized treatment approach eventually for ALL disease types beginning to take hold as standard of care. The new UK framework is leading the way worldwide. This and the commercial scale personalized manufacturing process (Flaskworks) developed by NWBO is why approval has been taking sooooo long in my opinion. Best wishes.
Market Data 
Markets 
AI
